首页> 外文学位 >Thermodynamic Study to Form More Stable and Soluble Drug-Polymer Mixtures Using SoluplusRTM and Its Component Homopolymers.
【24h】

Thermodynamic Study to Form More Stable and Soluble Drug-Polymer Mixtures Using SoluplusRTM and Its Component Homopolymers.

机译:使用SoluplusRTM及其组分均聚物形成更稳定和可溶的药物-聚合物混合物的热力学研究。

获取原文
获取原文并翻译 | 示例

摘要

Solid dispersions of crystalline drugs in polymer matrices are promising as an approach to improve bioavailability. However, the high energy of amorphous drug in a solid dispersion leads to crystallization. In this work, the Flory-Huggins Theory predicts the solubility of crystalline drugs in the triblock graft copolymer SoluplusRTM and its homopolymers components, namely polyvinyl caprolactam (PCL), polyvinyl acetate (PVAc), and polyethylene glycol (PEG). Evaluation of the physicochemical and in vitro characteristics of solid dispersions of each drug with SoluplusRTM and its component homopolymers was conducted.;Nifedipine (NIF) and sulfamethoxazole (SMX) of 99.3 and 99.5% purity, respectively, were selected as BCS II crystalline model drugs. The melting point depression of each drug measured at various polymer levels using differential scanning calorimetry (DSC) allowed calculation of chi, the interaction parameter. chi provides a measure of drugpolymer interaction strength and allows the estimation of the free energy of mixing of the drug with the polymer and, ultimately, its solubility in that polymer. Solubility is calculated by solving solubility equations and by construction of a phase diagram. A low molecular weight PEG was used as a solvent to experimentally measure model drug solubility. Solid dispersions were prepared by lyophilization and by spray drying. Drug crystallinity in the dispersions was evaluated by DSC. Dissolution studies were conducted in simulated gastric and intestinal fluids without enzymes at 37 °C.;The Flory-Huggins Theory indicates that SoluplusRTM interacts effectively with each drug. The predicted solubility in Soluplus RTM compared favorably across the two methods and with literature values. PVAc demonstrated weak interactions with each drug and it is unlikely to participate in drug solubilization. PCL was not a suitable candidate for the selected method due to its elevated Tg. SoluplusRTM and PEG 6000, however, interacted well with each drug, would solubilize them, and would enhance the dissolution rate in an aqueous medium; the dissolution rate for NIF improved to a greater extent than for SMX. Faster dissolution rates for PEG 6000 in comparison to SoluplusRTM dispersions were due to the more hydrophilic nature of PEG. DSC analysis revealed no crystalline material in the dispersions.
机译:结晶药物在聚合物基质中的固体分散体有望作为一种改善生物利用度的方法。然而,固体分散体中无定形药物的高能量导致结晶。在这项工作中,弗洛里-哈金斯理论预测了三嵌段接枝共聚物SoluplusRTM及其均聚物组分(即聚乙烯己内酰胺(PCL),聚乙酸乙烯酯(PVAc)和聚乙二醇(PEG))中结晶药物的溶解度。用SoluplusRTM及其组分均聚物评估每种药物的固体分散体的理化和体外特性;分别选择纯度分别为99.3和99.5%的硝苯地平(NIF)和磺胺甲恶唑(SMX)作为BCS II结晶模型药物。使用差示扫描量热法(DSC)在各种聚合物水平下测得的每种药物的熔点降低都可以计算出chi,即相互作用参数。 chi提供了药物-聚合物相互作用强度的量度,并允许估计药物与聚合物混合的自由能,并最终估计其在该聚合物中的溶解度。溶解度是通过求解溶解度方程式和构建相图来计算的。低分子量PEG用作溶剂,以实验方式测量模型药物的溶解度。通过冻干和通过喷雾干燥来制备固体分散体。通过DSC评估分散体中的药物结晶度。溶出度研究是在37°C下在无酶的模拟胃液和肠液中进行的;弗洛里-哈金斯理论表明,SoluplusRTM与每种药物都能有效地相互作用。预测的在Soluplus RTM中的溶解度在两种方法之间均具有良好的优势,并具有文献价值。 PVAc与每种药物的相互作用均较弱,因此不太可能参与药物溶解。由于PCL的Tg升高,因此不适合用于所选择的方法。但是,SoluplusRTM和PEG 6000与每种药物都有很好的相互作用,可以使它们溶解,并可以提高在水性介质中的溶解速度。与SMX相比,NIF的溶出率改善幅度更大。与SoluplusRTM分散体相比,PEG 6000的溶出速度更快是由于PEG具有更亲水的特性。 DSC分析表明分散体中没有结晶物质。

著录项

  • 作者单位

    University of the Sciences in Philadelphia.;

  • 授予单位 University of the Sciences in Philadelphia.;
  • 学科 Pharmaceutical sciences.;Physical chemistry.
  • 学位 Ph.D.
  • 年度 2015
  • 页码 257 p.
  • 总页数 257
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号